Cyclooxygenase-2 Modulates the Insulin-Like Growth Factor Axis in Non–Small-Cell Lung Cancer
Mehis Pǒld(MannKind Corporation (United States)), Steven M. Dubinett(University of California, Los Angeles)
Cited by 41
Related Papers
Secondary Lymphoid Tissue Chemokine Mediates T Cell-Dependent Antitumor Responses In Vivo
|The Journal of Immunology|2000|202
COVID-19 Vaccine Decision-making Factors in Racial and Ethnic Minority Communities in Los Angeles, California
|JAMA Network Open|2021|187
CXCL9/10-engineered dendritic cells promote T cell activation and enhance immune checkpoint blockade for lung cancer
|Cell Reports Medicine|2024|111
Inhibition of Granulocytic Myeloid-Derived Suppressor Cells Overcomes Resistance to Immune Checkpoint Inhibition in LKB1-Deficient Non–Small Cell Lung Cancer
|Cancer Research|2021|98
CCL21-DC in situ vaccination in murine NSCLC overcomes resistance to immunotherapy and generates systemic tumor-specific immunity
|Journal for ImmunoTherapy of Cancer|2023|30